ISSN 1062-936X (Print); ISSN 1029-046X (Online)
Publisher: Taylor and Francis Ltd
QSAR classification models for the screening of the endocrine-disrupting activity of perfluorinated compounds pp. 207-220(14) Authors: Kovarich, S.; Papa, E.; Li, J.; Gramatica, P.
The impact of network biology in pharmacology and toxicology pp. 221-235(15) Authors: Panagiotou, G.; Taboureau, O.
yaInChI: Modified InChI string scheme for line notation of chemical structures pp. 237-255(19) Authors: Cho, Y.S.; No, K.T.; Cho, K.-H.
Role of in silico genotoxicity tools in the regulatory assessment of pharmaceutical impurities pp. 257-277(21) Authors: Fioravanzo, E.; Bassan, A.; Pavan, M.; Mostrag-Szlichtyng, A.; Worth, A.P.
In Silico fragment-based drug design using a PASS approach pp. 279-296(18) Authors: Filz, O.A.; Lagunin, A.A.; Filimonov, D.A.; Poroikov, V.V.
QSTR modelling of the acute toxicity of pharmaceuticals to fish pp. 297-310(14) Authors: Tugcu, G.; Saçan, M. Türker; Vracko, M.; Novic, M.; Minovski, N.
Docking studies of novel pyrazinopyridoindoles class of antihistamines with the homology modelled H1-receptor pp. 311-325(15) Authors: Saxena, M.; Bhunia, S.S.; Saxena, A.K.
On graphical representation of trans-membrane proteins pp. 327-343(17) Authors: Randić, M.; Novič, M.; Choudhury, A. Roy; Plavšić, D.
Insight into eukaryotic topoisomerase II-inhibiting fused heterocyclic compounds in human cancer cell lines by molecular docking pp. 345-355(11) Authors: Taskin, T.; Yilmaz, S.; Yildiz, I.; Yalcin, I.; Aki, E.
Linear and non-linear QSAR modelling of juvenile hormone esterase inhibitors pp. 357-369(13) Authors: Devillers, J.; Doucet, J.P.; Doucet-Panaye, A.; Decourtye, A.; Aupinel, P.
Receive new issue alert